The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

Delgocitinib is a JAK inhibitor that blocks the activation of the JAK-STAT pathway which has been shown to play a key role in the pathophysiology of chronic inflammatory skin diseases.

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

When it comes to your baby’s delicate skin, especially on their face, finding the right moisturiser isn’t just a nice-to-have, it’s a must. Baby skin is thinner and more sensitive than adult skin, ...